Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
ACS Chemical Biology|April 26, 2007
Invertebrate animal models of diseases as screening tools in drug discoveryLaurent SégalatNeuromuscular Disorders : NMD|September 11, 2002
Dystrophin and functionally related proteins in the nematode Caenorhabditis elegansLaurent SégalatMedecine Sciences : M/S|December 24, 2003
[C. elegans as a model for human inherited degenerative diseases]Laurent Ségalat, Christian NériBritish Journal of Pharmacology|April 29, 2010
High-throughput screening and small animal models, where are we?Jean Giacomotto, Laurent SégalatGenetical Research|February 11, 2004
Target sequences of Tc1, Tc3 and Tc5 transposons of Caenorhabditis elegansVivian Préclin, Edwige Martin, Laurent SégalatEuropean Journal of Biochemistry|March 16, 2002
Dystrobrevin requires a dystrophin-binding domain to function in Caenorhabditis elegansKarine Grisoni, Kathrin Gieseler, Laurent SégalatJournal of Muscle Research and Cell Motility|May 12, 2007
The C. elegans dense body: anchoring and signaling structure of the muscleClaire Lecroisey, Laurent Ségalat, Kathrin GieselerNucleic Acids Research|August 18, 2004
Mos as a tool for genome-wide insertional mutagenesis in Caenorhabditis elegans: results of a pilot studyLaure Granger, Edwige Martin, Laurent SégalatMethods (San Diego, Calif.)|November 2, 2011
Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methodsJean Giacomotto, Laurent Ségalat, Maïté Carre-Pierrat, et al.Pageof 4